Unknown

Dataset Information

0

Characterization of Small-Molecule Scaffolds That Bind to the Shigella Type?III Secretion System Protein IpaD.

ABSTRACT: Many pathogens such as Shigella and other bacteria assemble the type?III secretion system (T3SS) nanoinjector to inject virulence proteins into their target cells to cause infectious diseases in humans. The rise of drug resistance among pathogens that rely on the T3SS for infectivity, plus the dearth of new antibiotics require alternative strategies in developing new antibiotics. The Shigella T3SS tip protein IpaD is an attractive target for developing anti-infectives because of its essential role in virulence and its exposure on the bacterial surface. Currently, the only known small molecules that bind to IpaD are bile salt sterols. In this study we identified four new small-molecule scaffolds that bind to IpaD, based on the methylquinoline, pyrrolidine-aniline, hydroxyindole, and morpholinoaniline scaffolds. NMR mapping revealed potential hotspots in IpaD for binding small molecules. These scaffolds can be used as building blocks in developing small-molecule inhibitors of IpaD that could lead to new anti-infectives.

SUBMITTER: Dey S 

PROVIDER: S-EPMC5741093 | biostudies-literature | 2017 Sep

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Characterization of Small-Molecule Scaffolds That Bind to the Shigella Type III Secretion System Protein IpaD.

Dey Supratim S   Anbanandam Asokan A   Mumford Ben E BE   De Guzman Roberto N RN  

ChemMedChem 20170831 18

Many pathogens such as Shigella and other bacteria assemble the type III secretion system (T3SS) nanoinjector to inject virulence proteins into their target cells to cause infectious diseases in humans. The rise of drug resistance among pathogens that rely on the T3SS for infectivity, plus the dearth of new antibiotics require alternative strategies in developing new antibiotics. The Shigella T3SS tip protein IpaD is an attractive target for developing anti-infectives because of its essential ro  ...[more]

Similar Datasets

Unknown Small-molecule type III secretion system inhibitors block assembly of the Shigella type III secreton.
| S-EPMC2620818 | biostudies-other
Unknown Shigella IpaD has a dual role: signal transduction from the type III secretion system needle tip and intracellular secretion regulation.
| S-EPMC3575693 | biostudies-literature
Unknown Shutting Down Shigella Secretion: Characterizing Small Molecule Type Three Secretion System ATPase Inhibitors.
| S-EPMC6298828 | biostudies-literature
Unknown Evaluation of immunogenicity and protective efficacy of orally delivered Shigella type III secretion system proteins IpaB and IpaD.
| S-EPMC3718310 | biostudies-literature
Unknown N-terminus of IpaB provides a potential anchor to the Shigella type III secretion system tip complex protein IpaD.
| S-EPMC3946325 | biostudies-literature
Unknown Ultrastructural analysis of IpaD at the tip of the nascent MxiH type III secretion apparatus of Shigella flexneri.
| S-EPMC3367090 | biostudies-literature
Unknown Self-chaperoning of the type III secretion system needle tip proteins IpaD and BipD.
| S-EPMC1894746 | biostudies-literature
Unknown Identification of small-molecule inhibitors of Yersinia pestis Type III secretion system YscN ATPase.
| S-EPMC3097197 | biostudies-literature
Unknown Deoxycholate-Enhanced Shigella Virulence Is Regulated by a Rare ?-Helix in the Type Three Secretion System Tip Protein IpaD.
| S-EPMC5761661 | biostudies-literature
Unknown Conformational changes in IpaD from Shigella flexneri upon binding bile salts provide insight into the second step of type III secretion.
| S-EPMC3130115 | biostudies-literature